Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAQTA in Healthy Chinese Children 12 to 23 Months of Age
NCT00835380Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Mar 2008
- Primary completion
- Oct 2008
- Modality
- Whole Inactivated Vaccines
01
Overview
A Phase 3 trial of inactivated hepatitis A virus vaccine in hepatitis A (HAV), sponsored by Merck & Co.. Started Mar 2008; status: completed.
02
Drugs
inactivated hepatitis A virus vaccine
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT00835380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00835380.